Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07854873) titled 'Vaginal Prasterone Versus Estriol in Women With Pelvic Floor Disorders' on Sept. 28.

Study Type: Interventional

Study Design: Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Poznan University of Medical Sciences

Condition: Pelvic Organ Prolapse (POP) Stress Urinary Incontinence (SUI)

Intervention: Drug: Prasterone (DHEA)

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: October 1, 2022

Target Sample Size: 74

Countries of Recruitment: Poland

To know more, visit https://clinicaltrials.gov/s...